Dr. Gupta Talks about Government’s Cannabinoid Patent

In a follow-up to his CNN documentary, WEED, Dr. Sanjay Gupta spoke on Anderson Cooper 360 about the patent that the US Government holds on cannabidiol: U.S. Patent 6,630,507, “Cannabinoids as antioxidants and neuroprotectants.” This patent, commonly known as “the ’507 Patent,” defines the benefits of CBD as recognized by the US Government. KannaLife Sciences, one of our investment holdings, has been awarded an exclusive license agreement with the National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the commercialization of this patent. From Raw Story:

  • “The U.S. holds a patent [on marijuana] on one hand, and on the other hand, same government says it has no medical applications,” Gupta told Cooper. “Journalists are trained to hate hypocrisy. This is hypocrisy. I’ve never seen it quite like this.”

The existence of this patent—filed over a decade ago—means that the US Government is at least nominally aware of the potential health benefits of CBD. Watch Dr. Gupta’s Anderson Cooper interview by clicking here. To learn more about KannaLife Sciences, visit their website at www.KannaLife.com.